BioGaia AB (publ)

OM:BIOG B Stock Report

Market Cap: SEK 10.2b

BioGaia Future Growth

Future criteria checks 4/6

BioGaia is forecast to grow earnings and revenue by 15% and 10.9% per annum respectively. EPS is expected to grow by 15% per annum. Return on equity is forecast to be 33.8% in 3 years.

Key information

15.0%

Earnings growth rate

15.0%

EPS growth rate

Biotechs earnings growth25.8%
Revenue growth rate10.9%
Future return on equity33.8%
Analyst coverage

Low

Last updated06 Mar 2025

Recent future growth updates

Recent updates

author-image

Launch Of Gastrus PURE ACTION And Direct Operations Will Strengthen Future Prospects

Feb 22 Direct market investments and internalizing operations in key regions enhance revenue potential by reducing reliance on distributors and capturing full retail margins.

BioGaia's (STO:BIOG B) Soft Earnings Don't Show The Whole Picture

Oct 29
BioGaia's (STO:BIOG B) Soft Earnings Don't Show The Whole Picture

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25
BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09
BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26
BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09
BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Feb 24
BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 10
BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

Nov 27
Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Sep 13
Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Jun 02
Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 27
A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Jan 14
Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Aug 26
Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24
Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02
Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21
BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09
Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07
BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Earnings and Revenue Growth Forecasts

OM:BIOG B - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,770476N/AN/A1
12/31/20251,578421N/AN/A1
12/31/20241,423351359373N/A
9/30/20241,356337365393N/A
6/30/20241,369402360394N/A
3/31/20241,300371323379N/A
12/31/20231,297365377426N/A
9/30/20231,273437361396N/A
6/30/20231,213415311342N/A
3/31/20231,186413310324N/A
12/31/20221,104374301319N/A
9/30/20221,036273262284N/A
6/30/2022952246286305N/A
3/31/2022867222263273N/A
12/31/2021785196215222N/A
9/30/2021767196215220N/A
6/30/2021725164201208N/A
3/31/2021766188177190N/A
12/31/2020747180205221N/A
9/30/2020767194155184N/A
6/30/2020802211155189N/A
3/31/2020780193147185N/A
12/31/2019768187109148N/A
9/30/2019770192133160N/A
6/30/2019778205152174N/A
3/31/2019756207161176N/A
12/31/2018742215170183N/A
9/30/2018702206N/A223N/A
6/30/2018675197N/A192N/A
3/31/2018631181N/A181N/A
12/31/2017615181N/A223N/A
9/30/2017584179N/A201N/A
6/30/2017562172N/A210N/A
3/31/2017542163N/A198N/A
12/31/2016535160N/A148N/A
9/30/2016500138N/A115N/A
6/30/2016480129N/A86N/A
3/31/2016478130N/A108N/A
12/31/2015483138N/A118N/A
9/30/2015500130N/A100N/A
6/30/2015474119N/A67N/A
3/31/201543297N/A55N/A
12/31/2014482147N/A124N/A
9/30/2014451146N/A126N/A
6/30/2014433145N/A163N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BIOG B's forecast earnings growth (15% per year) is above the savings rate (1.3%).

Earnings vs Market: BIOG B's earnings (15% per year) are forecast to grow faster than the Swedish market (13.4% per year).

High Growth Earnings: BIOG B's earnings are forecast to grow, but not significantly.

Revenue vs Market: BIOG B's revenue (10.9% per year) is forecast to grow faster than the Swedish market (2.8% per year).

High Growth Revenue: BIOG B's revenue (10.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BIOG B's Return on Equity is forecast to be high in 3 years time (33.8%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/14 14:21
End of Day Share Price 2025/04/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioGaia AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher UhdeABG Sundal Collier Sponsored
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Mattias HäggblomDanske Bank